Corticosteroid-responsive pharmacodynamic transcriptional markers: Results from a randomised placebo-controlled study of rheumatoid arthritis patients treated with prednisolone

被引：0
|
作者：
Dickson, Marion C. [1 ]
Ellis, Joanne [1 ]
Cai, Gengqian [2 ]
Wilson, Anthony G. [3 ]
Bridges, S. Louis, Jr. [4 ]
Furst, Daniel E. [5 ]
O'Dell, James R. [6 ]
El-Gabalawy, Hani S. [7 ]
Tiffany, Courtney [8 ]
Sidiqq, Shabanna [2 ]
Bal, Joanne [9 ]
Uings, Iain J. [1 ]
Binks, Michael H. [1 ]
机构：
[1] GSK, Stevenage, Herts, England
[2] GSK, Upper Merion, PA USA
[3] Univ Sheffield, Sheffield, S Yorkshire, England
[4] Univ Alabama, Birmingham, W Midlands, England
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Univ Nebraska, Omaha, NE 68182 USA
[7] Univ Manitoba, Winnipeg, MB, Canada
[8] GSK, Philadelphia, PA USA
[9] GSK, Greenford, Middx, England
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S774 / S774
页数：1
相关论文
共 50 条
  • [21] Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
    Aggarwal, Rohit
    Schessl, Joachim
    Charles-Schoeman, Christina
    Bata-Csorgo, Zsuzsanna
    Dimachkie, Mazen M.
    Griger, Zoltan
    Moiseev, Sergey
    Oddis, Chester V.
    Schiopu, Elena
    Vencovsky, Jiri
    Beckmann, Irene
    Clodi, Elisabeth
    Levine, Todd
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [22] Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
    Rohit Aggarwal
    Joachim Schessl
    Christina Charles-Schoeman
    Zsuzsanna Bata-Csörgő
    Mazen M. Dimachkie
    Zoltan Griger
    Sergey Moiseev
    Chester V. Oddis
    Elena Schiopu
    Jiri Vencovský
    Irene Beckmann
    Elisabeth Clodi
    Todd Levine
    Arthritis Research & Therapy, 26
  • [23] Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients
    Rech, Juergen
    Ostergaard, Mikkel
    Tascilar, Koray
    Hagen, Melanie
    Mendez, Larissa Valor
    Kleyer, Arnd
    Kroenke, Gerhard
    Simon, David
    Schoenau, Verena
    Hueber, Axel
    Kleinert, Stefan
    Baraliakos, Xenofon
    Fleck, Martin
    Rubbert-Roth, Andrea
    Behrens, Frank
    Kofler, David
    Feuchtenberger, Martin
    Zaenker, Michael
    Voll, Reinhard
    Glaser, Cornelia
    Feist, Eugen
    Burmester, Gerd
    Karberg, Kirsten
    Strunk, Johannes
    Canete, Juan D.
    Naredo, Esperanza
    Filkova, Maria
    Senolt, Ladislav
    Schett, Georg
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 939 - 941
  • [24] 16-Week Results from FOREMOST, a Placebo-Controlled Study Involving Oligoarticular Psoriatic Arthritis Treated with Apremilast
    Mease, Philip J.
    Gladman, Dafna
    Coates, Laura
    Aelion, Jacob
    Vasandani, Jitendra
    Kavanaugh, Arthur
    Merola, Joseph F.
    Reddy, Jyotsna
    Wang, Rebecca
    Brunori, Michele
    Colgan, Stephen
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3363 - 3365
  • [25] COMPARISON OF THE EFFICACY AND SAFETY OF TWO BRIDGING SCHEDULES OF PREDNISOLONE IN EARLY ACTIVE RHEUMATOID ARTHRITIS (CORRA): A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL
    Krause, D.
    Mai, A.
    Timmesfeld, N.
    Trampisch, U.
    Klaassen-Mielke, R.
    Rudolf, H.
    Baraliakos, X.
    Schmitz, E.
    Fendler, C.
    Klink, C.
    Boeddeker, S.
    Saracbasi, E.
    Christoph, J.
    Igelmann, M.
    Menne, H. J.
    Schmid, A.
    Trampisch, H. J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1000 - 1001
  • [26] Randomised double-blind placebo-controlled study of Tripterygium wilfordii, a Chinese herbal therapy, in rheumatoid arthritis.
    Cibere, J
    Den, ZZ
    Lin, YC
    Ou, RM
    He, YT
    Wang, ZQ
    Lehman, AJ
    Tsang, IK
    Esdaile, JM
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S291 - S291
  • [27] Randomised double-blind placebo-controlled study of Tripterygium Wilfordii, a Chinese herbal therapy, in rheumatoid arthritis.
    Cibere, J
    Deng, Z
    Lin, Y
    Ou, R
    He, Y
    Wang, Z
    Lehman, AJ
    Tsang, IK
    Esdaile, JM
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (06) : 1417 - 1417
  • [28] THERMAL INFRARED-REFLECTIVEWRIST SLEEVE FOR RHEUMATOID ARTHRITIS: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY
    Currey, J.
    Lightman, P.
    Chakravarty, K.
    Petty-Saphon, S.
    RHEUMATOLOGY, 2004, 43 : 48 - 49
  • [29] Atacicept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate Results of a Phase II, Randomized, Placebo-Controlled Trial
    van Vollenhoven, R. F.
    Kinnman, N.
    Vincent, E.
    Wax, S.
    Bathon, J.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (07): : 1782 - 1792
  • [30] A double-blind, placebo-controlled study to determine the effects of risedonate on bone Loss in glucocorticoid-treated rheumatoid arthritis patients
    Eastell, R
    Devogelaer, JP
    Peel, NFA
    Gill, C
    Bax, DE
    deDeuxchaisnes, CN
    Russell, RGG
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (11) : O3 - O3
12345